The invention generally relates to blood collection and processing systems and methods.
Systems composed of multiple, interconnected plastic bags have met widespread use and acceptance in the collection, processing and storage of blood components. Using these systems, whole blood is collected and separated into its clinical components (typically red blood cells, platelets, and plasma). The components are individually stored and used to treat a multiplicity of specific conditions and diseased states.
Before storing blood components for later transfusion, it is believed to be desirable to minimize the presence of impurities or other materials that may cause undesired side effects in the recipient. For example, because of possible reactions, it is generally considered desirable to remove substantially all the leukocytes from blood components before storage, or at least before transfusion.
Filtration is conventionally used to accomplish leuko-reduction. Systems and methods for reducing the number of leukocytes by filtration in multiple blood bag configurations are described, e.g., in Stewart U.S. Pat. No. 4,997,577, Stewart et al. U.S. Pat. No. 5,128,048, Johnson et al. U.S. Pat. No. 5,180,504, and Bellotti et. al. U.S. Pat. No. 5,527,472.
One aspect of the invention provides a blood filter comprising a filter pad assembly comprising at inlet layer, an outlet layer, and at least one intermediate layer that comprises a fiber filter media. The filter also includes a filter housing comprising a first flexible housing element that overlays the inlet layer of the filter pad assembly and a second flexible housing element that overlays the outlet layer of the filter pad assembly. The filter further includes a peripheral seal formed by the application of radio frequency heating and pressure in a single step, which joins the first and second flexible housing elements directly to the filter pad assembly. The peripheral seal comprises a commingled melted matrix comprising material of the first and second housing elements and fiber filter media of the filter pad assembly. The blood filter also includes an inlet port in the first housing element spaced from the peripheral seal for conveying blood to the filter pad assembly, and an outlet port in the second housing element spaced from the peripheral seal for conveying blood from the filter pad assembly.
In a preferred embodiment, the fiber filter medium removes leukocytes from blood.
Other features and advantages of the invention will become apparent upon review of the following description, drawings, and appended claims.
The invention is not limited to the details of the construction and the arrangements of parts set forth in the following description or shown in the drawings. The invention can be practiced in other embodiments and in various other ways. The terminology and phrases are used for description and should not be regarded as limiting.
As shown in
The transfer bag 14 is intended to receive platelet-rich plasma separated from the whole blood collected in the primary bag 12. Attempts are made when transferring the platelet-rich plasma out of the primary bag 12 to keep as many leukocytes in the primary bag 12 as possible. The transfer of platelet-rich plasma into the transfer bag 14 leaves the red blood cells and the leukocytes behind in the primary bag 12.
The transfer bag 16 contains a suitable storage solution S for red blood cells. One such solution is disclosed in Grode et al U.S. Pat. No. 4,267,269, which is sold by Baxter Healthcare Corporation under the brand name ADSOL® Solution. The storage solution S is transferred into the primary bag 12 after transfer of the platelet-rich plasma into the transfer bag 14.
The platelet-rich plasma is centrifugally separated by conventional means in the transfer bag 14 into platelet concentrate and platelet-poor plasma. The platelet-poor plasma is transferred into the transfer bag 16, which is now emptied of storage solution S. The transfer bag 16 serves as the storage container for the platelet-poor plasma. The transfer bag 14 serves as its storage container for the platelet concentrate.
The storage solution S is mixed with the red blood cells and leukocytes remaining in the primary bag 12. The mixture of storage solution S, red blood cells, and leukocytes is transferred from the primary bag 12 through tubing 26. The tubing 26 carries in-line the integral, flexible filter 20. The flexible filter 20 includes a filtration medium 28 contained within a housing 30. The filtration medium is selected to remove leukocytes from red blood cells.
The leukocyte-reduced red blood cells enter the transfer bag 18. The transfer bag 18 serves as the storage container for the leukocyte-reduced red blood cells.
The bags and tubing associated with the processing system 10 can all be made from conventional approved medical grade plastic materials, such as polyvinyl chloride plasticized with di-2-ethylhexylphthalate (PVC-DEHP). The bags are formed using conventional heat sealing technologies, e.g., radio frequency (RF) heat sealing.
Alternatively, since the transfer bag 14 is intended to store the platelet concentrate, it can be made of polyolefin material (as disclosed in Gajewski et al U.S. Pat. No. 4,140,162) or a polyvinyl chloride material plasticized with tri-2-ethylhexyl trimellitate (TEHTM). These materials, when compared to DEHP-plasticized polyvinyl chloride materials, have greater gas permeability that is beneficial for platelet storage.
The flexible filter 20, like the rest of the system 10, is a disposable, single use item. Also, like the rest of the system 10, the filter housing 30 is made using conventional approved medical grade plastic materials. Furthermore, like the rest of the system 10, the filter housing 30 is formed using conventional radio frequency heat sealing technology. The filter 20, being flexible, facilitates handling and reduces the incidence of damage to other components of the system 10 during centrifugal processing.
In the illustrated embodiment (see
The filtration medium 28 is made from a fibrous material, which is sandwiched between the sheets 32 and 34. The filtration medium 28 can be arranged in a single layer or in a multiple layer stack. The medium 28 can include melt blown or spun bonded synthetic fibers (e.g., nylon or polyester or polypropylene), semi-synthetic fibers, regenerated fibers, or inorganic fibers. In use, the medium 28 removes leukocytes by depth filtration.
In the illustrated embodiment, the filtration medium 28 comprises, in the blood flow direction, a prefilter region, a main filter region, and a postfilter region. The prefilter and postfilter are made of fibrous material (e.g., polyethylene) having a pore size and fiber diameter not suited for leukocyte removal. Instead, the fibrous material of the prefilter is sized to remove gross clots and aggregations present in the blood. The fibrous material of the postfilter is sized to provide a fluid manifold effect at the outlet of the filter. In a representative embodiment, the prefilter material has a pore size of between about 15 μm to about 20 μm, and the postfilter material has a pore size of about 20 μm. The main filter region is made of a fibrous material (e.g., polyethylene) having a pore size and diameter sized to remove leukocytes by depth filtration. The material of the main filter region can have the characteristics described in Watanabe et al. U.S. Pat. No. 4,701,267 or Nishimura et al. U.S. Pat. No. 4,936,998, which are incorporated herein by reference.
As disclosed, the filtration medium 28 can be made symmetric, meaning that the material layers of filtration medium encountered during flow through the medium 28 are the same regardless of the direction of flow. Thus, either side of the medium 28 can serve as an inlet or an outlet. The symmetric nature of the filtration medium 28 further simplifies manufacture, as it is not necessary to differentiate between “inlet” and “outlet” side of the filtration medium 28 or “inlet” or “outlet” orientation of the sheets 32 and 34.
According to the invention, a unitary, continuous peripheral seal 36 is formed by the application of pressure and radio frequency heating in a single process to the two sheets 32 and 34 and filtration medium 28. The seal 36 joins the two sheets 32 and 34 to each other, as well as joins the filtration medium 28 to the two sheets 32 and 34. The seal 36 integrates the material of the filtration medium 28 and the material of the plastic sheets 32 and 34, for a reliable, robust, leak-proof boundary. Since the seal 36 is unitary and continuous, the possibility of blood shunting around the periphery of the filtration medium 30 is eliminated.
The filter 20 also includes inlet and outlet ports 38 and 40. The ports 38 and 40 comprise tubes made of medical grade plastic material, like PVC-DEHP. As
The symmetric orientation of filtration medium 28, described above, makes the filter 30 “non-directional.” The port 38 can be oriented to serve either as an inlet port or an outlet port, with the other port 40 serving, respectively, as the corresponding outlet port or inlet port, and vice versa.
The filter 20 (see
As the dies 50 and 52 apply pressure about the peripheral edge, RF energy is applied through the dies 50 and 52, The combination of RF energy and pressure softens the plastic material of the sheets 32 and 34. The applied pressure causes the heat softened material of the sheets 32, 34 to penetrate the interstices of the filtration medium 28, creating an interior matrix of sheet material commingled with filtration medium material. Within the matrix, the filtration medium melts, creating a composite seal 36.
At its surface, along the sheets 32 and 34, the seal 36 comprises mostly the material of the sheets 32 and 34. With increasing distance from the surface, the seal 36 comprises a commingled melted matrix of the material of the sheets 32 and 34 and the material of the filtration medium 28. This is believed to occur because the sheet material, which is electrically heated and caused to flow by the applied radio frequency energy, is further caused by the applied pressure to flow into and penetrate the interstices of the medium 28. The heated sheet material that flows under pressure into the interstices of the medium 28 causes the medium 28 itself to melt about it.
After a brief period of cooling, the seal 36 sets and the dies 50 and 52 are withdrawn. In a representative embodiment, the dies 50 and 52 are coupled to a 4 KW radio frequency energy generator. Pressure of 60 PSI is applied, maintaining a die gap of 1.2 mm. A sealing time of about 5.5 seconds is realized, followed by a cooling time of about 5 seconds.
As
As
Once integrated into the system 10, the flexible filter housing 30 comprises a variable volume reservoir that can be used, after filtration, to receive residual air trapped in the transfer bag 18. In this arrangement, after leukocyte-depleted red blood cells have been transferred from the filter 20 into the bag 18, residual air is expressed from the transfer bag 18 back into the filter housing 30. Tubing upstream of the filter 20 can be clamped closed to trap air in the filter housing 30. Being flexible, the housing 30 expands to accommodate the residual air volume.
Alternatively, the residual air in the transfer bag 18 can be transferred back into the primary bag 12 through an air vent path that bypasses the filter 20. For example, as
Instead of the tubing path 60 (see
A flexible filter can be integrated in different ways into multiple blood bag systems. For example (see
As another example,
The transfer bag 76 receives the leukocyte-depleted platelet-rich plasma, leaving the leukocyte-depleted red blood cells in the transfer bag 74 for storage. The platelet-rich plasma is centrifugally separated by conventional means in the transfer bag 76 into platelet concentrate and platelet-poor plasma. The platelet-poor plasma is transferred into the transfer bag 78 for storage. This leaves the platelet concentrate in the transfer bag 76, which serves as its storage container.
The flexible filter that embodies the invention avoids the handling and processing problems rigid filter housings have presented in the past. Unlike a rigid housing, the flexible housing 30 will not puncture associated bags, which are also made of flexible plastic materials. Unlike a rigid housing, the flexible housing 30 conforms and is compliant to stress and pressures induced during use.
The close proximity of the flexible sheet 32 and the filtration medium 28 on the inlet side of the filter 20 creates a capillary effect, which promotes displacement of air and automatic priming of the filter 30 under the fluid head pressure of gravity flow from a source container. The fluid head pressure causes the flexible sheet 32 to distend or expand after priming. It thus creates a natural pressure manifold, which evenly distributes the fluid across the inlet face of the filtration medium 28. This assures that entrapped air is vented and that the fluid flows through the filtration medium 28 under uniform pressure and distribution.
As the fluid container empties, negative pressure is created downstream of the filter 20. Because the inlet and outlet sheets 32 and 34 of the housing 30 are flexible, they will collapse around the space occupied by the filtration medium 28, minimizing the amount of residual blood left in the filter 30 after use. Fluid drains from the outlet side without the use of an auxiliary air vent.
By the same process, the flexible filter 30 provides a visual indication of an upstream occlusion or blockage during use. If an occlusion occurs in the inlet tubing upstream of the filter 30 during use (e.g., by formation of a kink in the tubing or by formation of an in-line blood clot), the inlet and outlet sheets 32 and 34 of the housing 30 will respond by collapsing, in the same fashion occasioned by an empty source container. Thus, an unexpected collapse of the filter 30 during use visually signifies the presence of an occlusion upstream of the filter 30.
Furthermore, the flexible housing 30 will not crack during heat sterilization. The flexible housing 30 also does not impede heat penetration during heat sterilization processes. Instead, the housing 30 accommodates uniform heat penetration into the filtration medium 28. The filter 20 can undergo sterilization at the same time the entire system 10 is sterilized, making a one-step sterilization process possible.
Various features of the invention are set forth in the following claims.
This application is a division of U.S. application Ser. No. 10/159,442, filed May 31, 2002 (now U.S. Pat. No. 6,745,902), which is a division of U.S. application Ser. No. 09/593,782 filed 14 Jun. 2000 (now U.S. Pat. No. 6,422,397), which is a continuation-in-part of application Ser. No. 09/498,085 filed 4 Feb. 2000 (now U.S. Pat. No. 6,367,634, which is a continuation-in-part of U.S patent application, Ser. No. 08/697,270, filed Aug. 21, 1996 (now U.S. Pat. No. 6,032,807), which is a continuation of U.S. Pat. application Ser. No. 08/558,458, filed Nov. 16, 1995 (now abandoned), which is a continuation of U.S. Pat. application Ser. No. 08/392,297, filed Feb. 22, 1995 (now abandoned), which is a continuation of U.S. Pat. application Ser. No. 08/173,608, filed Dec. 22, 1993 (now abandoned).
Number | Name | Date | Kind |
---|---|---|---|
3506130 | Shaye | Apr 1970 | A |
3747769 | Brumfield | Jul 1973 | A |
4025618 | Garber et al. | May 1977 | A |
4035304 | Watanabe | Jul 1977 | A |
4066556 | Vaillancourt | Jan 1978 | A |
4113627 | Leason | Sep 1978 | A |
4157967 | Meyst et al. | Jun 1979 | A |
4170056 | Meyst et al. | Oct 1979 | A |
4193876 | Leeke et al. | Mar 1980 | A |
4211825 | Shipman | Jul 1980 | A |
4234026 | Bayham | Nov 1980 | A |
4235233 | Mouwen | Nov 1980 | A |
4240481 | Bayham | Dec 1980 | A |
4268338 | Peterson | May 1981 | A |
4305443 | Bayham | Dec 1981 | A |
4380484 | Repik et al. | Apr 1983 | A |
4412835 | Spencer | Nov 1983 | A |
4417753 | Bacehowski et al. | Nov 1983 | A |
4425177 | Shinno | Jan 1984 | A |
4437472 | Naftulin | Mar 1984 | A |
4460366 | Shinno | Jul 1984 | A |
4466888 | Verkaart | Aug 1984 | A |
4482585 | Ohodaira et al. | Nov 1984 | A |
4493705 | Gordon et al. | Jan 1985 | A |
4507123 | Yoshida | Mar 1985 | A |
4539793 | Malek | Sep 1985 | A |
4707402 | Thorsrud | Nov 1987 | A |
4767541 | Wisdom | Aug 1988 | A |
4770295 | Carveth et al. | Sep 1988 | A |
4798578 | Ranford | Jan 1989 | A |
4857129 | Jensen et al. | Aug 1989 | A |
4863603 | Lehmann et al. | Sep 1989 | A |
4892537 | Carmen et al. | Jan 1990 | A |
4892603 | Lustig et al. | Jan 1990 | A |
4892604 | Measells et al. | Jan 1990 | A |
4894107 | Tse et al. | Jan 1990 | A |
4900389 | Schnell et al. | Feb 1990 | A |
4900441 | Graus et al. | Feb 1990 | A |
4950347 | Futagawa | Aug 1990 | A |
4954251 | Barnes et al. | Sep 1990 | A |
4976851 | Tanokura et al. | Dec 1990 | A |
4997577 | Stewart | Mar 1991 | A |
5049146 | Bringham et al. | Sep 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5066290 | Measells et al. | Nov 1991 | A |
5180504 | Johnson et al. | Jan 1993 | A |
5190657 | Heagle et al. | Mar 1993 | A |
5225014 | Ogata et al. | Jul 1993 | A |
5269924 | Rochat | Dec 1993 | A |
5306269 | Lewis et al. | Apr 1994 | A |
5316678 | Heaslip | May 1994 | A |
5360498 | Blomqvist et al. | Nov 1994 | A |
5420962 | Bakke | May 1995 | A |
5435878 | Delmar et al. | Jul 1995 | A |
5449428 | Desmarais et al. | Sep 1995 | A |
5489385 | Raabe et al. | Feb 1996 | A |
5507904 | Fisher et al. | Apr 1996 | A |
5527472 | Bellotti et al. | Jun 1996 | A |
5556541 | Ruschke | Sep 1996 | A |
5575880 | Strassberg | Nov 1996 | A |
5580349 | Thor et al. | Dec 1996 | A |
5591337 | Lynn et al. | Jan 1997 | A |
5601730 | Page et al. | Feb 1997 | A |
5683768 | Shang et al. | Nov 1997 | A |
5688460 | Ruschke | Nov 1997 | A |
5724988 | Dennehey et al. | Mar 1998 | A |
5728249 | Kinsey, Jr. et al. | Mar 1998 | A |
5728306 | Breillatt, Jr. et al. | Mar 1998 | A |
5736719 | Lawson et al. | Apr 1998 | A |
5772880 | Lynn et al. | Jun 1998 | A |
5853577 | Gizowski et al. | Dec 1998 | A |
5858016 | Bacehowski et al. | Jan 1999 | A |
5976300 | Buchanan et al. | Nov 1999 | A |
6032807 | Sternberg et al. | Mar 2000 | A |
6367634 | Lynn et al. | Apr 2002 | B1 |
6422397 | Lynn et al. | Jul 2002 | B1 |
6745902 | Lynn et al. | Jun 2004 | B2 |
Number | Date | Country |
---|---|---|
0155003 | Sep 1985 | EP |
0155055 | Sep 1985 | EP |
0328038 | Feb 1989 | EP |
0 365 676 | May 1990 | EP |
0365676 | May 1990 | EP |
0526678 | Dec 1991 | EP |
0 516 846 | Dec 1992 | EP |
0 521 222 | Jan 1993 | EP |
0 525 493 | Feb 1993 | EP |
0526678 | Feb 1993 | EP |
0614675 | Dec 1993 | EP |
0679490 | Sep 1994 | EP |
0 654 303 | May 1995 | EP |
684867 | Dec 1995 | EP |
07-267871 | Oct 1995 | JP |
WO9507818 | Mar 1995 | WO |
WO9517237 | Jun 1995 | WO |
Number | Date | Country | |
---|---|---|---|
20040149646 A1 | Aug 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10159442 | May 2002 | US |
Child | 10761850 | US | |
Parent | 09593782 | Jun 2000 | US |
Child | 10159442 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 08558458 | Nov 1995 | US |
Child | 08697270 | US | |
Parent | 08392297 | Feb 1995 | US |
Child | 08558458 | US | |
Parent | 08173608 | Dec 1993 | US |
Child | 08392297 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09498085 | Feb 2000 | US |
Child | 09593782 | US | |
Parent | 08697270 | Aug 1996 | US |
Child | 09498085 | US |